direct to consumer genetic testing public right or public harm greismann intersect the stanford journal of science technology and society article tools print this article indexing metadata how to cite item review policy email this article login required email the author login required post a comment login required user username password remember me journal content search all authors title abstract index terms full text browse by issue by author by title other journals information for readers for authors for librarians home about current archives what is sts home vol 2 no 1 2009 greismann direct to consumer genetic testing public right or public harm libby greismann abstract direct to consumer genetic testing is a new technology that provides consumers with relative risks of over 90 diseases conditions and traits bypassing the healthcare profession completely allowing private companies to market their products directly to consumers worries have emerged about the risks of consumer vulnerability in light of the average person's ignorance about genetics and subsequent consequences of uninformed decisions about personal health thus the issue emerges of whether the government has the right to regulate the technology at all or whether this regulation would be infringing on the protectable interest of knowing information about your own body keywords ethics society genetics rights full text pdf bookmark and share creative commons license this work is licensed under a creative commons attribution 3.0 license
